IRCT2017050723235N10
已完成
3 期
Rush Immunotherapy effects on the gene expression of IL- 4, FoxP3, TGF-ß, IL-17, IL-10 and IFN-? in the perennial allergic rhinitis patients
Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 16 人待定
概览
- 阶段
- 3 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Perennial allergic rhinitis.
- 发起方
- Vice chancellor for research, Mashhad University of Medical Sciences
- 入组人数
- 16
- 状态
- 已完成
- 最后更新
- 8年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •The risk of perennial allergic rhinitis; Positive skin test to allergens in the air; Clinical signs associated with skin test
- •Exclusion criteria: History of autoimmune disease; Patients with systemic corticosteroids or immunosuppressive drugs for reasons other than allergic disease on the immune system use to be effective; Pregnancy; Immunocompromised patients, patients who have uncontrolled allergic asthma; Patients with malnutrition; Patients who received beta\-blocker drugs; Patients with a history of anaphylaxis; patients With coexisting cardiovascular disease; During treatment, patients who are experiencing systemic reactions; Patients with mental disorders
排除标准
- 未提供
结局指标
主要结局
未指定
相似试验
招募中
不适用
Analysis of therapy-induced changes in gene expression, tumorigenicity and invasiveness of circulating, epithelial tumor cells (CETCs)C18C19C20Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectumDRKS00015530niversität Bayreuth100
已完成
2 期
ImmunoModulation effects of early therapeutic NORMothermia in febrile severe Septic patientsSepsissepsistherapeutic normothermiafever controlimmunomodulationneutrophil chemotaxiscytokinesCD11bmHLA-DRTCTR20160321001Faculty of Medicine, Chulalongkorn University15
招募中
3 期
Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level studyCTRI/2020/06/025861Department of Ayush Uttarakhand
招募中
不适用
Study protocol for the HARMONY studyKCT0005173Korea Institute of Oriental Medicine200
已完成
4 期
Characterization of the immuno-modulatory effects of Tecfidera in multiple sclerosis patients: exploration of drug mechanism and methodological feasibility.Reduced lymphocyte count. Reduced white bloodcell count.10047954NL-OMON42490Centre for Human Drug Research16